Pulmatrix, Inc.
Pulmatrix develops inhaled therapeutic products for migraine and respiratory diseases using its iSPERSE dry powder delivery platform.
8-KNov 17Latest SEC filing
Nov 17Latest story
November 2026
August 2026
Pulmatrix develops inhaled therapeutic products for migraine and respiratory diseases using its iSPERSE dry powder delivery platform.